Literature DB >> 2678579

The immunological component of the cellular inflammatory infiltrate in bronchiectasis.

J R Silva1, J A Jones, P J Cole, L W Poulter.   

Abstract

Immunohistological analysis of bronchial biopsy specimens from nine patients with bronchiectasis and four control subjects was performed with a panel of monoclonal antibodies selected to show lymphocyte and macrophage subsets and signs of cellular activation. The cells taking part in the inflammatory response in the bronchial wall of patients with bronchiectasis were almost exclusively mononuclear cells, most of them T lymphocytes. B lymphocytes were observed in biopsy specimens from only two out of nine patients. CD8+ T cells outnumbered CD4+ cells in all patients in a ratio ranging from 2:1 to 10:1. Most T lymphocytes also strongly expressed CD7 antigen and a proportion of them expressed HLA-DR. Most of the lymphocytic infiltration occurred just beneath the basement membrane of the epithelium, though intraepithelial and submucosal infiltration was also seen. Non-lymphoid mononuclear cells expressing the phenotype of dendritic cells and macrophages were found dispersed throughout the infiltrate, most of them expressing HLA-DR. These observations support the hypothesis that cell mediated immunological reactions contribute to the inflammation associated with bronchiectasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678579      PMCID: PMC462004          DOI: 10.1136/thx.44.8.668

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  A study of the pathology and pathogenesis of bronchiectasis.

Authors:  F WHITWELL
Journal:  Thorax       Date:  1952-09       Impact factor: 9.139

Review 2.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

3.  Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.

Authors:  C G Kallenberg; B M Schilizzi; F Beaumont; S Poppema; L De Leij; T H The
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

4.  Gut- and bronchus-associated lymphoid tissue.

Authors:  J Bienenstock; D Befus
Journal:  Am J Anat       Date:  1984-07

5.  Parasitism of antigen presenting cells in hyperbacillary leprosy.

Authors:  L W Poulter; L A Collings; K S Tung; M F Waters
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

Review 6.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract.

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-26       Impact factor: 91.245

Review 7.  T cell subpopulations, monoclonal antibodies and their therapeutic applications.

Authors:  G Janossy; H G Prentice
Journal:  Clin Haematol       Date:  1982-10

8.  The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

Authors:  D A Campbell; R M du Bois; R G Butcher; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

9.  Activated T lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies.

Authors:  L W Poulter; O Duke; G S Panayi; S Hobbs; M J Raftery; G Janossy
Journal:  Scand J Immunol       Date:  1985-12       Impact factor: 3.487

10.  An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

View more
  18 in total

Review 1.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 2.  Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Marcel Bonay; Catherine Bancal; Bruno Crestani
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

Authors:  R A Stockley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

4.  Cellular elements organization in the trachea of mallard (Anas platyrhynchos) with a special reference to its local immunological role.

Authors:  Doaa M Mokhtar; Marwa M Hussien
Journal:  Protoplasma       Date:  2019-11-13       Impact factor: 3.356

5.  Distribution of immunocompetent cells in the bronchial wall of clinically healthy subjects showing bronchial hyperresponsiveness.

Authors:  C Power; S Sreenan; B Hurson; C Burke; L W Poulter
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

6.  Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.

Authors:  M Gaga; A M Bentley; M Humbert; J Barkans; F O'Brien; C G Wathen; A B Kay; S R Durham
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

7.  Mycobacteria as a cause of infective exacerbation in bronchiectasis.

Authors:  C H Chan; A K Ho; R C Chan; H Cheung; A F Cheng
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

8.  Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity.

Authors:  R J Boyton; J Smith; M Jones; C Reynolds; L Ozerovitch; A Chaudhry; R Wilson; M Rose; D M Altmann
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

Review 9.  Helicobacter pylori infection and respiratory diseases: a review.

Authors:  Anastasios Roussos; Nikiforos Philippou; Konstantinos I Gourgoulianis
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

Review 10.  Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis.

Authors:  R J Boyton; C J Reynolds; K J Quigley; D M Altmann
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.